2011, Number 1
<< Back Next >>
Revista Cubana de Cirugía 2011; 50 (1)
Malignant meningioma
González OY, Elizondo BL, Junco MR, Rojas MJ, Duboy LV, Pérez VA
Language: Spanish
References: 18
Page: 108-114
PDF size: 183.46 Kb.
ABSTRACT
The intracranial meningiomas are tumors in general of benign type of a slow growth originating in the arachnoid cells layer, especially in arachnoid granulations. The anaplastic or malignant meningiomas accounted for only the 1-3%. Sometimes they simulate malignant neuroepithelial lesions due to its fast growth and the frequent invasion of surrounding cerebral tissue with very frequent relapses and many times they required adjuvant therapy. The topographic images of this type of tumor are hyper-denses with a good contrast capture, regular and well defined with not much or not associated edema, quite the contrary that observed in present case where images seems to correspond with those of a malignant glioma (multiforme glioblastoma).
REFERENCES
Gutmann DH, Donahoe J, Perry A. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 2000;9:1495-500.
Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery 2003;53:62-71.
Beaumont A, Whittle IR. The pathophysiology of tumour associated epilepsy. Acta Neurochir Wien 2000;142:115.
Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002;99:4257-64.
Gursan N, Gondogdu C, Albayrak A, Kabalar ME. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labelling indices in paraffin-embedded sections of meningiomas. Int J Neurosci 2002;112:463-70.
Nagashima G, Asai J, Suzuki R, Fujimoto T. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF and PgR expression. Brain Tumor Pathol 2001;18:15.
Murakami M, Hashimotos N, Takahashi Y, Hosokawa Y, Inazawa J, Mineura K. A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression. Cancer Genet Cytogenet 2003;140:99-106.
Perry A, Banerjee R, Lohse CM, Kleinschmidt-DeMasters BK, Scheithauer BW. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 2000;12: 83-90.
Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000;92:766-70.
Lieu AS, Howng SL. Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Res 2000;38:45-52.
McDermott MW, Wilson CB. Meningeomas. Neurological Surgery 1997;4:127-159.
Ikeda H, Yoshimoto T. Immunohistochemical study of anaplastic meningioma with special reference to the phenotypic change of intermediate filament protein. Annals of Diagnostic Pathology 2003;7:214-22.
Ho DM, Hsu CY, Ting LT, Chiang H. Histopathology of MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 2002;94:1538-47.
Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22-39.
Pollock BE, Stafford SL, Utter A, Gianni C, Schreiner SA. Stereotactic radiosurgery provides equivalent tumour control to Simpson Grade 1 resection for patients with small to medium size meningiomas. Int J Radiat Oncol Biol Phys 2003;55:1000-5.
Flickinger JC, Kondziolka D, Maitz AH, Lunsford LD. Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma. Int J Radiat Oncol Biol Phys 2003;56:801-06.
Narayan S, Cornblath WT, Sandler HM, Elner V, Hayman JA. Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2003;56:537-43.
Becker G, Jeremic B, Pitz S. Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2002;54:1422-29.